However, clinical studies have demonstrated that immunotherapy can significantly improve survival in advanced PCC patients, especially in those with an Eastern Cooperative Oncology Group (ECOG) performance status of 0 and high PD‐L1 expression [58]. The gene discussed is CD274; the disease is adrenal gland pheochromocytoma.